Predictors of Symptomatic Intracranial Hemorrhage in Off ‐label Thrombolysis: an Analysis of the SITS registry
ConclusionsThrombolysis appears to be safe regarding symptomatic intracranial haemorrhage for most of the off‐label criteria, especially for minor stroke, but is risky in patients with high blood pressure. Individual risk‐benefit evaluation should be performed.This article is protected by copyright. All rights reserved.
Source: European Journal of Neurology - Category: Neurology Authors: Sibu Mundiyanapurath, Katharina Hees, Niaz Ahmed, Nils Wahlgren, Lorenz Uhlmann, Meinhard Kieser, Peter Arthur Ringleb, Werner Hacke, Simon Nagel Tags: Original Article Source Type: research
More News: Activase | Brain | Databases & Libraries | Diabetes | Endocrinology | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Neurology | Stroke